Brain Cancer

Study title





The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.

Eligibility criteria

To be considered for this study you must meet the following criteria:

  • you have histologically confirmed glioblastoma
  • evidence of relapsed GBM as per a recent MRI
Study details

Your participation in this study will require you to attend on two days for PET scans. The scans will take approximately 90 minutes. A blood sample will be collected – approximately 30mls at baseline.

This study will help ensure the optimal targeting of anti-cancer treatment and imaging in the future.

Sign up to this clinical trial below.


Brunton Ave, Melbourne VIC 3004, Australia

Further information